Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

2.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
3.

[Three paradigms in the treatment of posttraumatic stress disorder].

Martényi F.

Neuropsychopharmacol Hung. 2005 Mar;7(1):11-21. Review. Hungarian.

PMID:
16167463
5.

Efficacy of tianeptine in major depressive disorders with or without melancholia.

Ginestet D.

Eur Neuropsychopharmacol. 1997 Oct;7 Suppl 3:S341-5. Review.

PMID:
9405961
6.

Response characteristics to antidepressants and placebo in post-traumatic stress disorder.

Davidson JR, Malik ML, Sutherland SN.

Int Clin Psychopharmacol. 1997 Nov;12(6):291-6. Review.

PMID:
9547130
7.
8.

Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.

Davis LL, English BA, Ambrose SM, Petty F.

Expert Opin Pharmacother. 2001 Oct;2(10):1583-95. Review.

PMID:
11825301
9.

New pharmacological approaches to the management of depression: from theory to clinical practice.

Norman TR, Judd FK, Burrows GD.

Aust N Z J Psychiatry. 1992 Mar;26(1):73-81. Review. Erratum in: Aust N Z J Psychiatry 1992 Jun;26(2):332.

PMID:
1580888
10.

[Therapeutic effects of tianeptine in patients with depression and anxiety disorders with or without associated alcoholism].

Marey C, Ganry H, Delalleau B, Kamoun A.

Presse Med. 1991 Nov 14;20(37):1828-36. Review. French.

PMID:
1836615
11.

Tianeptine: a review of its use in depressive disorders.

Wagstaff AJ, Ormrod D, Spencer CM.

CNS Drugs. 2001;15(3):231-59. Review.

PMID:
11463130
12.

Review of sertraline in post-traumatic stress disorder.

Schwartz AC, Rothbaum BO.

Expert Opin Pharmacother. 2002 Oct;3(10):1489-99. Review.

PMID:
12387695
13.

Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials.

Defrance R, Marey C, Kamoun A.

Clin Neuropharmacol. 1988;11 Suppl 2:S74-82. Review.

PMID:
2902922
14.

Treatment of posttraumatic stress disorder: the impact of paroxetine.

Davidson JR.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:76-88. Review.

PMID:
14566203
15.

Antidepressant treatment of posttraumatic stress disorder.

Pearlstein T.

J Clin Psychiatry. 2000;61 Suppl 7:40-3. Review.

16.

The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder.

Bajor LA, Ticlea AN, Osser DN.

Harv Rev Psychiatry. 2011 Sep-Oct;19(5):240-58. doi: 10.3109/10673229.2011.614483. Review.

PMID:
21916826
17.

The role of moclobemide in endogenous depression: a survey of recent data.

Woggon B.

Int Clin Psychopharmacol. 1993 Jan;7(3-4):137-9. Review.

PMID:
8468434
18.

Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies.

Penava SJ, Otto MW, Pollack MH, Rosenbaum JF.

Depress Anxiety. 1996-1997;4(5):240-2. Review. No abstract available.

PMID:
9167791
19.
20.

Treatment-resistant posttraumatic stress disorder: strategies for intervention.

Hamner MB, Robert S, Frueh BC.

CNS Spectr. 2004 Oct;9(10):740-52. Review.

PMID:
15448585
Items per page

Supplemental Content

Support Center